Mandate

Vinge advices CapMan on acquisition of Nacka Närsjukhus Proxima

June 28, 2007

Vinge is advising funds managed by CapMan on the acquisition of Nacka Närsjukhus Proxima. Nacka Närsjukhus Proxima is a modern healthcare provider that offers specialised healthcare services from emergency unit to complex surgery within various specialities, such as orthopaedics. The company serves primarily the greater Stockholm area and the Stockholm County Council as well as other county councils in Sweden. The transaction is subject to regulatory approvals and other customary closing conditions.

The Vinge team advising CapMan includes partners Jan Byström, and Ulf Sallnäs and associates Mats Hävermark, Philip Asmar, Johanna Rutberg and Per Westman. Partner Mikael Ståhl advises CapMan on the financing of the acquisition. Partner Johan Karlsson and associate Emma Nörler provide competition law advice.

Related

Vinge advises parts of the consortium in connection with the public takeover offer for Cint

The public takeover offer was announced by a consortium consisting of Triton Fund 6, Bolero, Patrick Comer and Brett Schnittlich. The offer values all shares in Cint at approximately SEK 1,989 million. The shares in Cint are listed on Nasdaq Stockholm, Mid Cap.
April 27, 2026

Nordea and SEB enters into a SEK 2,000,000,000 credit facility agreement

On 22 April 2026, Nordea and SEB entered into a credit facility agreement in the aggregate amount of SEK 2,000,000,000 (with an accordion option for an additional SEK 400,000,000) with Humble Group AB (publ).
April 27, 2026

Vinge has advised Northmill in connection with its inaugural issuance of primary capital instruments (AT1)

Vinge has advised Northmill Group AB in connection with its issuance of SEK 275 million primary capital instruments (so called “AT1 bonds”) with a floating rate interest of 3-month STIBOR + 690 basis points. The AT1 bonds are perpetual with a first call option after five years and are intended to be admitted to trading on Nasdaq Transfer Market and, subsequently, on Nasdaq Stockholm.
April 27, 2026